A randomized double-blind controlled trial of a probiotic pharmacologic food complex formulation to intervene in obesity

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Intervention group:Use of probiotic medicinal food compound food preparation;Control group:placebo; CONDITION: Obesity PRIMARY OUTCOME: Fasting blood glucose;Fasting insulin;Glycosylated hemoglobin;C‐peptide;Diet and exercise;Intestinal flora analysis; SECONDARY OUTCOME: Liver function;Renal function;Blood lipids;Leptin;Adiponectin;TCM symptoms;Body composition analysis ; INCLUSION CRITERIA: (1) Meet the above Chinese and Western medical diagnostic criteria; (2) Any gender, age 18‐60 years old; (3) Not treated with meal replacements, enzymes, diet pills, or other weight loss techniques; (4) Those who can persist in completing the trial, while strictly following the treatment cycle and cooperating with the doctor in clinical treatment and data measurement; (5) Voluntarily participate and sign the consent form.
Epistemonikos ID: 25f02f8730c479ff658371a924a5b734d52bf277
First added on: Feb 20, 2024